Rtw Investments, LP Edwards Lifesciences Corp Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $6.17 Million - $7.45 Million	-145,246 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $827,328 - $1.06 Million	22,246 Added 18.09%	145,246 $20.3 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $4.16 Million - $4.84 Million	123,000	123,000 $13.9 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.